Scisparc Ltd
NASDAQ:SPRC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Chandra Bhagat Pharma Ltd
BSE:542934
|
IN |
|
P
|
Photon Capital Advisors Ltd
BSE:509084
|
IN |
|
OSG Corporation Co Ltd
TSE:6757
|
JP |
Scisparc Ltd
Total Current Assets
Scisparc Ltd
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Scisparc Ltd
NASDAQ:SPRC
|
Total Current Assets
$7.5m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
51%
|
CAGR 10-Years
44%
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Total Current Assets
$193.1m
|
CAGR 3-Years
12%
|
CAGR 5-Years
2%
|
CAGR 10-Years
9%
|
|
|
Enlivex Therapeutics Ltd
NASDAQ:ENLV
|
Total Current Assets
$19.5m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-2%
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Total Current Assets
$186m
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Total Current Assets
$17m
|
CAGR 3-Years
4%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Pluri Inc
NASDAQ:PLUR
|
Total Current Assets
$13.8m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-11%
|
|
Scisparc Ltd
Glance View
Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
See Also
What is Scisparc Ltd's Total Current Assets?
Total Current Assets
7.5m
USD
Based on the financial report for Dec 31, 2024, Scisparc Ltd's Total Current Assets amounts to 7.5m USD.
What is Scisparc Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
44%
Over the last year, the Total Current Assets growth was 16%. The average annual Total Current Assets growth rates for Scisparc Ltd have been -9% over the past three years , 51% over the past five years , and 44% over the past ten years .
